DossierENTITY

Bio-Techne

Coverage of Bio-Techne in the Nexus archive.

Earliest in view: Jun 25 · 10:16 UTCMost recent: Jun 26 · 14:20 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJun 26 · 14:20 UTCQUARTZ
Germany's Merck KGaA is buying lab-tools supplier Bio-Techne for $11.3 billion
Germany's Merck KGaA is acquiring lab-tools supplier Bio-Techne for $11.3 billion, marking its largest deal since the Sigma-Aldrich buyout. The acquisition expands Merck's presence in proteins, spatial biology, and cell and gene therapy.
BUSINESSJun 25 · 10:16 UTCFINANCIAL TIMES WORLD
German drugmaker Merck to buy Bio-Techne in $11.3bn deal
German drugmaker Merck is acquiring US medical tools maker Bio-Techne in a $11.3 billion deal, marking the German group's largest acquisition in over a decade.